SNHG22

gene
On this page

Also known as SCARNA17HG

Summary

SNHG22 (small nucleolar RNA host gene 22, HGNC:50285) is a long non-coding RNA gene on chromosome 18q21.1.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:50285
Approved symbolSNHG22
Namesmall nucleolar RNA host gene 22
Location18q21.1
Locus typeRNA, long non-coding
StatusApproved
AliasesSCARNA17HG
Ensembl geneENSG00000267322
Ensembl biotypelncRNA
Entrez103091864
RNAcentralURS00001118C6 — lncRNA, 1615 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 5 lncRNA

ENST00000589499, ENST00000615535, ENST00000617833, ENST00000782330, ENST00000782331

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000589499 — 4 exons

ExonStartEnd
ENSE000027861924981402349814062
ENSE000027908904984963749851059
ENSE000028250254983927649839364
ENSE000028529674984036349840425

Expression profiles

Bgee: expression breadth ubiquitous, 167 present calls, max score 99.56.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 397.0163 / max 10809.8577, expressed in 1823 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
170242397.01631823

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
colonic epitheliumUBERON:000039799.56gold quality
sural nerveUBERON:001548898.74gold quality
bone marrow cellCL:000209298.03gold quality
calcaneal tendonUBERON:000370197.69gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047391.59gold quality
adrenal tissueUBERON:001830387.16gold quality
hindlimb stylopod muscleUBERON:000425285.24gold quality
granulocyteCL:000009483.85gold quality
right lobe of liverUBERON:000111483.14gold quality
left ovaryUBERON:000211980.76gold quality
right ovaryUBERON:000211880.66gold quality
monocyteCL:000057679.99gold quality
leukocyteCL:000073879.89gold quality
esophagogastric junction muscularis propriaUBERON:003584179.42gold quality
lower esophagus muscularis layerUBERON:003583379.06gold quality
lower esophagusUBERON:001347379.01gold quality
muscle layer of sigmoid colonUBERON:003580578.57gold quality
muscle of legUBERON:000138377.81gold quality
tibial nerveUBERON:000132377.26gold quality
adenohypophysisUBERON:000219677.25gold quality
apex of heartUBERON:000209877.10gold quality
bloodUBERON:000017876.88gold quality
ascending aortaUBERON:000149676.71gold quality
tendonUBERON:000004376.61gold quality
small intestine Peyer’s patchUBERON:000345476.59gold quality
liverUBERON:000210776.47gold quality
thoracic aortaUBERON:000151576.43gold quality
body of uterusUBERON:000985376.43gold quality
left uterine tubeUBERON:000130376.41gold quality
lower esophagus mucosaUBERON:003583476.39gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.68

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 6)

  • lncRNA SNHG22 sponges miR1283p to promote the progression of colorectal cancer by upregulating E2F3. (PMID:34368861)
  • Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p. (PMID:34652260)
  • ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis. (PMID:34663788)
  • SNHG22 promotes migration and invasion of trophoblasts via miR-128-3p/PCDH11X axis and activates PI3K/Akt signaling pathway. (PMID:35679761)
  • LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis. (PMID:36281526)
  • Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer. (PMID:39300525)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): microvillus inclusion disease